Company / Working Capital per Share
Denali Therapeutics Inc. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.56
FY2025
5-year range
$4.31 / $8.25
FY2021-FY2025
Trend
+1.0%
vs FY2024
Sector context
#103 of 210
Health Care
What the data says
At $5.56, Denali Therapeutics Inc.'s working capital per share ranks #103 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $5.56.
Based on SEC 10-K filings.
5.56 in FY2025 with a 5-year CAGR of -17.8%.
Declined from $7.25 to $5.56 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -12.3%
- 5-Year CAGR
- -17.8%
- 10-Year CAGR
- -
Sector benchmark
#103 of 210 in Health CareTop 49% of 210This company $5.56 Sector average $118.60
▼
-95.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 1.0% year-over-year.
- Ranks #103 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2017.
- Lowest working capital per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.73 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.56 | +1.0% |
| FY2024 | $5.51 | -24.1% |
| FY2023 | $7.25 | -12.0% |
| FY2022 | $8.25 | +91.5% |
| FY2021 | $4.31 | -70.9% |
| FY2020 | $14.80 | +264.3% |
| FY2019 | $4.06 | -20.7% |
| FY2018 | $5.12 | -80.6% |
| FY2017 | $26.43 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026